The effect of albumin administration on renal dysfunction after experimental surgical obstructive jaundice in male rats  by Saad, Ramadan A. et al.
Ar
6
a
G
4
e
g
c
w
a
r
r
©
(
K
P
h
1
(Journal of Taibah University for Science 10 (2016) 877–886
Available  online  at  www.sciencedirect.com
ScienceDirect
The effect of albumin administration on renal dysfunction after
experimental surgical obstructive jaundice in male rats
Ramadan A. Saad a, Mohamed F. FathelBab b,∗, Abdelaleem A. El-Saba c,
Abeir A. Shalaby d
a Department of Physiology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
b Department of Physiology, Faculty of Medicine, Helwan University, Cairo, Egypt
c Department of Histology and Cytology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt
d Department of Biochemistry, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt
Available online 28 May 2015
bstract
The aim was to study the influence of albumin supplementation on the changes of the kidney function and structure in cirrhotic
ats induced by common bile duct ligation (BDL). Twenty-four male albino rats weighing 200–250 g were divided into Group  I:
 rats underwent laparotomy alone, and the bile duct was only dissected from the surrounding tissue; Group  II: 6 rats underwent
 sham operation and received 2% albumin in their drinking water; Group  III: 6 rats were subjected to bile duct ligation only; and
roup  IV:  6 rats were subjected to bile duct ligation and received a daily albumin 2% in drinking water. All rats were sacrificed after
 weeks. We measured the liver and kidney functions and oxidative stress markers in the renal tissue and conducted a histological
valuation of the liver and kidney. The liver enzymes were decreased, but there was no significant difference in the bilirubin levels in
roup IV compared to group III. There was a significant elevation of serum creatinine in group III compared to group II, and serum
reatinine was attenuated in group IV. The renal tissue catalase activity and reduced glutathione, as well as the nitric oxide levels,
ere significantly increased in group IV and were elevated in group III. Histologically, the livers of group IV showed degeneration
nd inflammatory cell infiltration with regeneration areas in which normal hepatocytes appeared. The kidneys of group IV showed
ecovery as well as areas of inflammatory cell infiltration. Some tubules appeared with normal epithelial lining. In conclusion, the
esults suggest that albumin partially improves the renal functions and structures after their disturbances as a result of BDL.
 2015 Taibah University. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Cholestatic (Obstructive) jaundice occurred within
2 weeks of common bile duct ligation (BDL) and. This is an open access article under the CC BY-NC-ND license
progressed to cirrhosis within 4 to 6 weeks [1]. The
patients with cholestatic jaundice may have a higher
incidence of renal dysfunction, and approximately
6–8% of the patients suffer from acute renal injury,
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with mortality over 68% [2]. Renal dysfunction sec-
ondary to liver cirrhosis, which was experimentally
induced by BDL, is known as hepatorenal syndrome
(HRS) [3].
The oxidative stress and generation of reactive oxy-
gen species (ROS) secondary to cholestasis could give
rise to the involvement of remote organs other than
the liver, such as the kidney with alterations in its
function [4]; antioxidant administration improves these
alterations [5]. Experimentally, the in vitro addition of
excess bile acids or bilirubin to a mixture of reactive
enzymes inhibited mitochondrial oxidative enzymes.
Thus, high concentrations of these substances in the
blood may explain the development of renal failure
during cholestatic liver disorders [6]. The blockage
of the biliary pathway in cholestasis may cause an
overload on the kidney with a consequent disturbance
of the kidney function, which may progress to renal
failure [7].
Albumin is a liver protein; its production depends on
food intake and the integrity of liver cells. The main
function of albumin is the maintenance of the colloidal
osmotic pressure of the plasma and interstitial fluid
[8]. Moreover, albumin plays a significant antioxidant
role because of its ability to reduce the production of
free radicals by leukocytes [9]. Patients with a reduced
serum albumin level are more liable to the dangers of
oxidative stress and excess free radicals [10]. Recently,
albumin infusion was shown to improve renal function
in decompensated cirrhotic patients with acute kidney
injury by impacting on the renal blood flow autoregula-
tion [11].
This study was designed with the aim of evaluating the
renal function parameters and renal histological changes
in rats subjected to a ligation of the extrahepatic bile duct
and the influence of albumin supplementation in these
animals.
2.  Materials  and  methods
2.1.  Animals
The present study was performed on adult male
albino rats weighing 200–250 g. The rats were purchased
from Vacsera  Animal  House  (Helwan)  and were main-
tained in the Physiology Department Animal House
under standard conditions of boarding and feeding. The
given diet consisted of bread, milk and green vegetables,
and the diet and water were provided ad libitum. All
surgical procedures were performed with diethyl ether
inhalation.sity for Science 10 (2016) 877–886
2.2.  Experimental  protocol
2.2.1.  Animal  groups
Twenty-four male albino rats were divided into four
groups:
• Group  I:  sham/untreated  (n  = 6) rats underwent
laparotomy with handling of the bile ducts, but with-
out ligation of the bile duct and were sacrificed 4  weeks
after the manipulation.
• Group  II:  sham/treated  (n  = 6) rats underwent a sham
operation and received 2% albumin (aqueous solu-
tion) ad libitum and were sacrificed 4  weeks  after
manipulation.
• Group  III:  BDL/untreated  (n  = 6) rats underwent
laparotomy with ligation of the common bile duct and
were sacrificed 4  weeks  after the common bile duct
ligation.
• Group  IV:  BDL/treated  (n  = 6) rats underwent laparo-
tomy with ligation of the common bile duct, were
treated with 2% (albumin aqueous solution) ad libitum
[12], and were sacrificed 4 weeks  after the common
bile duct ligation.
Rats in the sham-operated group were subjected to a
1.5-cm upper midline abdominal incision, and the com-
mon bile duct was isolated from the surrounding tissues.
The rats in the BDL group underwent the same proce-
dure and the common bile duct was doubly ligated with
a 4–0 silk suture and transected between the two liga-
tures. The rats were subjected to either bile duct ligation
(BDL) or the sham operation using aseptic techniques,
as previously described by [13].
During the period of the study, the animals were kept
at room temperature and were subjected to a light/dark
cycle of 12 h each. All animals received rat chow and
water ad libitum, whereas in the case of the animals in
the treated groups (groups II and IV), the water contained
2% albumin.
After the end of the experimental period, animals
were anaesthetized by an overdose of diethyl ether and
were sacrificed, blood was collected, and the liver and
kidney were excised and weighed immediately and pre-
served in parafilm and 10% formalin for biochemical and
histological analyses, respectively.
2.2.2. Blood  samples  collection
Initially, a few drops of blood were collected ina heparinized capillary tube that was centrifuged by
microcentrifuge to determine the haematocrit value.
Most of the blood collected was then centrifuged to
separate the serum, which was stored at −20 ◦C for
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ater measurements of bilirubin, aminotransferases and
lkaline phosphatase, as well as measurements of blood
rea nitrogen (BUN) and serum creatinine and albumin.
.2.3. Tissue  samples
Tissue samples were obtained from the liver and
he kidney. The renal tissue level of malondialdehyde
MDA) and glutathione (GSH), as well as catalase activ-
ty, were determined.
Hepatic and renal tissue samples were examined
nder a light microscope for histopathological changes.
.2.4. Liver  function  parameters
Measurement of the serum levels of albumin [14],
otal bilirubin (TB) and direct bilirubin (DB) [15];
lkaline phosphatase enzyme (ALP) [16]; alanine
minotransferase (ALT), and aspartate aminotransferase
AST) [17].
.2.5.  Renal  function  parameters
BUN (mg/dl) [18] and serum creatinine (mg/dl) [19]
ere measured by the colorimetric method using kits
upplied by Biodiagnostic (Egypt).
.2.6. Measurement  of  the  oxidative  stress
arameters  and  nitric  oxide  in  renal  tissue
The level of lipid peroxides, measured as malondi-
ldehyde (MDA) [20], in addition to the level of reduced
lutathione (GSH) [21], was determined in the kidney
omogenates. The units used to express these concen-
rations were mol/g of renal tissue.
.2.6.1. Catalase  activity  (CAT).  The catalase activity
as determined by the method of Aebi [22]. The enzyme
ctivity is expressed as units per milligram of protein
U/mg protein). The kits used in the tissue analysis were
upplied by Biodiagnostic (Egypt).
.2.6.2. NO  determination.  As a NO measurement is
ery difficult to perform in biological specimens, the
able 1
aematocrit value and ratios of the liver and kidney-to-body weight in the dif
arameters Groups
Sham/untreated Group I Sham/treat
aematocrit value (%) 42 ± 1.02 40 ± 1.1
iver to body weight ratio (%) 3.15 ± 0.25 3.09 ± 0.3
idney to body weight ratio (%) 0.29 ± 0.05 0.32 ± 0.0
alues are the means ± SEM.
* Significance compared to the sham control groups.sity for Science 10 (2016) 877–886 879
tissue nitrite (NO2) plus nitrate (NO3) concentrations
were estimated as an index of the NO production.
A method for determining the tissue NO2 plus NO3
levels based on the Griess reaction was used [23]. The
total nitrite (NOX) (NO2 + NO3) was measured by a
spectrophotometer at 545 nm. The results are expressed
as nanomole per gram of wet hepatic tissue.
2.2.7.  Histological  analysis
Liver and kidney tissue were fixed in 10% buffered
formaldehyde and were then processed and embedded
in paraffin and sectioned (5 m). These sections were
stained and viewed by light microscopy.
2.3.  Statistical  analysis
Data were entered and analyzed using SPSS version
9.0. All of the values were expressed as the mean ±  SEM.
The significance of the data obtained was evaluated by
using analysis of variance (ANOVA). P  values of less
than 0.05 were considered significant.
3.  Results
Four weeks after the BDL, the animals had typi-
cal signs of cirrhosis, such as decreased growth and
jaundice. After death, an abdominal inspection revealed
diffuse yellow-green pigmentation in the abdominal
organs and a small amount of ascites in many rats in
the BDL group. Furthermore, all animals presented with
mesenteric oedema and an enlarged liver and spleen
(indirect evidence of portal hypertension).
3.1.  General  parametersAs shown in Table 1, there was no significant dif-
ference in the haematocrit values between the different
groups. All of the BDL rats (group III and IV) had higher
liver and kidney-to-body weight ratios than the sham
ferent experimental groups.
ed Group II BDL/untreated Group III BDL/treated Group IV
4 39 ± 2.04 38 ± 1.01
5 5.10 ± 0.55* 4.15 ± 0.33*
3 0.41 ± 0.02* 0.39 ± 0.03*
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control groups (groups I and II). No significant change
was observed between the sham control groups.
3.2.  Liver  and  kidney  functions  parameters
As shown in Table 2, the levels of total and direct
bilirubin is commonly used in patients to evaluate
cholestasis. Total and direct bilirubin were increased in
the BDL group compared to the sham group. The admin-
istration of albumin did not influence significantly the
level of bilirubin in the serum.
The AST, ALT and ALP serum levels are considered
to be markers of hepatocyte destruction. The AST, ALT,
and ALP levels were significantly increased in group III
in comparison with the sham groups. However, the AST,
ALT, and ALP levels were decreased in group IV com-
pared to group III, but were still higher than for the sham
control group. Serum albumin decreased significantly in
the BDL group and was nearly corrected after albumin
supplementation in group IV.
There was a tendency to an increased level of creat-
inine in group III compared to the sham control group.
The albumin supplementation significantly decreased
the creatinine level towards normal. There was no
significant change in the BUN between the different
experimental groups.
3.3.  Renal  tissues  levels  of  ROS  and  NO
The MDA  levels  were significantly greater in the kid-
ney homogenates prepared from the BDL rats than those
measured in the kidney homogenates from the sham
control groups. These levels were reduced in the BDL
rats with the albumin treatment. However, there were no
Table 2
Kidney and liver function parameters in the different experimental groups.
Parameters Groups
Sham/untreated Group I Sham/treated Gro
T. BIL (mg/dl) 0.32 ± 0.02 0.25 ± 0.05 
D. BIL (mg/dl) 0.08 ± 0.009 0.05 ± 0.009 
AST (IU/l) 57.99 ± 6.34 43.46 ± 4.56 
ALT (IU/l) 32.47 ± 5.92 36.22 ± 4.61 
ALP (IU/l) 75.78 ± 8.6 66.62 ± 6.16 
Albumin (gm/dl) 2.97 ± 0.13 3.57 ± 0.36 
BUN (mg/dl) 40.61 ± 6.16 35.37 ± 5.22 
Creatinine (mg/dl) 0.25 ± 0.09 0.31 ± 0.08 
Values are the means ± SEM.
* Significance compared to the sham control groups.
¥ Significance between group III and IV.Fig. 1. Levels of renal tissue MDA in different experimental groups.
The results are the means and standard errors. *Significance compared
to the sham control groups.
significant differences between the two groups of sham
control rats (Fig. 1).
The mean renal level of GSH  in the BDL group
was significantly lower than in the sham control groups.
These levels were increased in the BDL rats with the
albumin treatment. Furthermore, there were no signifi-
cant differences between the two groups of sham control
rats (Fig. 2).
Catalase activity  in the BDL group was significantly
lower than in the sham control groups. However, this
activity was increased in the BDL rats receiving the albu-
min treatment. Furthermore, there were no significant
differences between the two groups of sham control rats
(Fig. 3).
NO levels  were significantly greater in the kidney
homogenates prepared from the BDL rats than those
measured from the sham control groups. These levels
were reduced in the BDL rats with the albumin treat-
ment. Furthermore, there were no significant differences
between the two groups of sham control rats (Fig. 4).
up II BDL/untreated Group III BDL/treated Group IV
10.17 ± 2.02* 9.11 ± 1.42*
5.11 ± 1.02* 6.09 ± 1.12*
722.22 ± 92.1* 381 ± 44.6*,¥
208.28 ± 45.2* 122.56 ± 41.8*,¥
361.98 ± 71.3* 218.27 ± 41.5*,¥
1.51 ± 0.83* 2.78 ± 0.59¥
32.44 ± 7.03 39.16 ± 4.38
1.21 ± 0.15* 0.79 ± 0.08*,¥
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he sham control groups. ¥Significance between groups III and IV.
.4.  Histopathological  examination
.4.1.  Liver
The liver of the sham control rats presented with a
ormal histological structure; the hepatic lobules were
ntact with a normal arrangement of the hepatic plates
hat radiated from the central vein (Fig. 5a). The hepato-
ytes appeared regular, with normal cytoplasmic density
nd normal nuclear morphology. The bile ducts were
ntact (Fig. 5b).
Four  weeks  after  bile  duct  ligation, the livers of the
ats showed severe centrilobular fibrosis and prominent
ile duct proliferation in the portal tracts (Fig. 5c). The
epatocytes in the areas of the proliferating bile ducts
ere atrophied with an increase of collagen in the hepatic
arenchyma. Generally, this followed the proliferation
rocess of the bile ducts 30 days after the BDL (Fig. 5d).
The liver of the rats in the albumin treated group
howed some degree of degeneration and inflammatory
ig. 3. Tissue catalase activity in the different experimental groups.
he results are the means and standard errors. *Significance compared
o the sham control groups. ¥Significance between groups III and IV.Fig. 4. Tissue NO levels in the different experimental groups. The
results are the means and standard errors. *Significance compared to
the sham control groups. ¥Significance between groups III and IV.
cell infiltration (Fig. 5e) with some areas of regeneration
in which normal hepatocytes appeared (Fig. 5f).
3.4.2. Kidney
The kidney of the rat in the control group appeared
with normal renal parenchyma, spherical shaped renal
corpuscles with normal glomerulus and intact Bow-
man’s capsules. Additionally, the proximal and distal
convoluted tubules appeared with intact healthy lin-
ing epithelium and the loop of Henle (Fig. 6a) and
the collecting tubules appeared with normal epithelium
(Fig. 6b).
Four weeks  after  bile  duct  ligation, the kidneys of the
rats showed severe damage. The renal medulla presented
some regenerated tubules with inflammatory cell infiltra-
tion in some parts (Fig. 6c). The renal corpuscles showed
thickening in some parts with swelling in the glomeru-
lus, and the cortical capillaries appeared engorged with
blood; some areas of haemorrhage were also observed.
Eosinophilic homogenous fluid was observed in the
spaces between the renal tubules (Fig. 6d). Also swelling
in the tubules and hypertrophy in their epithelium was
observed. Some of the tubules were completely ruptured
(Fig. 6e).
The kidneys of the rats in the albumin-treated group
showed some recovery as the homogenous fluid between
the tubules decreased. There were areas of inflamma-
tory cell infiltration, and some tubules showed a wide
lumen. Some tubules appeared with a somewhat normal
epithelial lining (Fig. 6f).
4.  DiscussionThe present study confirms the association between
liver injury and oxidative stress. In this study, albu-
min administration caused a significant reduction in the
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Fig. 5. (a) Photomicrograph of a liver of a sham untreated albino rat showing normal hepatic lobulation and normal hepatic plates (H&E 400×).
(b) Photomicrograph of a liver of a sham treated albino rat showing normal hepatic plates; note hepatocytes with normal cytoplasmic density and
normal nuclei (H&E 1000×). (c) Photomicrograph of a liver of an albino rat 4 weeks after BDL showing severe hepatic fibrosis (H&E 400×). (d)
Photomicrograph of a liver of an albino rats 4 weeks after BDL showing the hepatic lobules replaced with collagenic fibrosis (c) and the newly
graph o
n) (H&formed bile ducts (D). (Crossmon’s trichrome 400×). (e) Photomicro
areas with inflammatory cells infiltration (D) and some normal areas (
albino rat showing some normal hepatocytes (arrow) (H&E 400×).
destructive parameters of cholestasis and in the activities
of hepatic injury enzymes. Furthermore, albumin signif-
icantly improved the parameters of oxidative stress and
caused a significant increase in the antioxidant enzyme
activities in the renal tissue.
The BDL rats showed marked disturbances in
liver function that was manifested in this study byf a liver from a BDL/Albumin treated albino rat showing degenerated
E 200×). (f) Photomicrograph of a liver from a BDL/Albumin treated
elevated serum levels of AST; ALT; bilirubin, mainly
the direct portion; and ALP. The elevated liver function
parameters can be considered to be an indicator of the
success of the surgery. This finding is in agreement
with many other studies [24]. The serum liver enzymes
decreased significantly in the albumin-treated rats,
but the serum bilirubin remained elevated despite the
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Fig. 6. (a) Photomicrograph of a renal medulla of a sham untreated albino rat showing normal thin segments of the loop of Henle (arrow) and
collecting tubules (c) (H&E 320×). (b) Photomicrograph of a kidney of a sham treated albino rat showing normal thick segments of the loop of
Henle (arrow) (H&E 200×). (c) Photomicrograph of a kidney from a BDL/Albumin treated albino rat showing some recovery in some renal medulla
with decrease the interlobular fluid and some focal area of lymphocytic infiltration (arrow). (H&E 400×). (d) Photomicrograph of a kidney from
an albino rat 4 weeks after BDL showing severe renal damage. Note the swelling of renal corpuscles (R), haemorrhage (arrow) and eosinophilic
fluid (arrow head) of granulose cells (arrow head) (H&E 100×). (e) Photomicrograph of a kidney from an albino rat 4 weeks after BDL showing
swelling in the renal corpuscles (R) with vacuolated and damaged epithelium of the tubules (arrow), some of which appeared to be ruptured (arrow
head) (H&E 400×). (f) Photomicrograph of a kidney from a BDL/Albumin treated albino rat showing recovery in some renal corpuscles (R) and
r ell (arro
a
l
l
senal tubules (arrow head). Note the infiltration of the inflammatory c
lbumin administration. However, the serum albumin
evel decreased significantly in the BDL rats, most
ikely due to the increased leakage outside the vascular
ystem and a lack of compensation due to the hepaticw) and wide tubules (w) (H&E 400×).
damage [25]. Such a decline was corrected by albumin
administration. Previous studies also found a decline in
the levels of albumin in rat plasma starting two weeks
after common bile duct ligation [26].
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It was demonstrated that HRS is characterized by
functional rather than structural disarrangement of the
kidneys in the presence of progressive liver disease [27].
In the current work, the BDL rats showed a disturb-
ance in renal function, as revealed by elevated serum
creatinine levels. This is in agreement with previous stud-
ies [28,29]. The BDL/Albumin treated rats showed mild
improvement in renal function, as evidenced by a signif-
icant decrease in serum creatinine, which, was still more
than the control value. It has been reported that at early
stages of hepatic injury, renal compensatory mechanisms
still remain operating with no observed disturbance of
renal function [30]. It was also demonstrated that the
administration of albumin prevents the deterioration of
renal function and reduces mortality in these patients
[31].
In the present study, we found reduced levels of GSH
and catalase activity, but the MDA content in the kid-
ney homogenate of the BDL rats was elevated compared
with the controls. These results suggest enhanced lipid
peroxidation, which causes tissue damage, in addition
to the failure of the antioxidant defence mechanisms
that prevent the formation of excessive free radicals.
The results suggest the development of liver necrosis
and cholestasis, which is evident after 72 h; however,
lipid peroxidation started after 1–2 weeks of BDL [32].
Our results are in agreement with Ercin et al. [33], who
reported that  in BDL rats, the activity of the antioxidant
systems diminished, which is responsible for the inhibi-
tion of the free oxygen radicals. The administration of
albumin significantly increased the catalase activity and
GSH level as well as reduced the MDA level and thus
reduced reactive free radical induced oxidative damage,
protected the tissues from highly reactive hydroxyl radi-
cals and attenuated lipid peroxidation in the kidney of
the BDL rats.
Regarding the NO content in the kidney tissue, there
was a significant decrease in the NO in the renal tissue of
the BDL rats with albumin treatment after its elevation
in the BDL rats. The excessive generation of NO has
been observed both in experimental cholestasis [34,35]
and in primary biliary cirrhosis patients [36,37]. Renal
impairment occurs in cirrhotic patients with a high con-
centration of NO in the plasma and ascitic fluid. Such
impairment was improved by the inhibition of NO syn-
thase, thus decreasing NO [38]. The excess NO in the
BDL rats may be one of the factors responsible for
the observed renal disturbances. The peripheral arterial
vasodilation produced by the NO with relative arterial
underfilling activates the sympathetic nervous system
with severe renal vasoconstriction and consequent renal
ischaemia that may end in renal failure in the advancedsity for Science 10 (2016) 877–886
stage. Thus, in the present work, the albumin decreased
nitric oxide in the BDL rats, which would be expected
to attenuate the development of the renal disturbances
resulting from excess nitric oxide. It was also demon-
strated that the superoxide anion can rapidly react with
NO, resulting in peroxynitrite formation, which can sub-
sequently initiate lipid peroxidation [39].
In the BDL rats, the liver showed severe centrilob-
ular fibrosis and prominent bile duct proliferation. The
hepatocytes in the areas of the proliferating bile ducts
were atrophied with an increase of collagen in the hepatic
parenchyma. It was reported that BDL in rats stimulates
the proliferation of biliary epithelial cells and hepatocyte
progenitors, resulting in proliferating bile ductules with
accompanying portal inflammation and fibrosis. Cholan-
giocyte proliferation is initiated after the BDL at the
edge of the portal tract [1]. However, the liver of rat
in the BDL/albumin treated group showed some degree
of degeneration and inflammatory cell infiltration with
some areas of regeneration in which normal hepatocytes
appeared.
In the BDL rats, the renal corpuscles showed thick-
ening in some parts with swelling in the glomerulus,
and the cortical capillaries appeared to be engorged with
blood with haemorrhagic areas. Additionally, swelling
in the tubules and hypertrophy in their epithelium were
observed. Some of the tubules were completely ruptured.
However, some researchers demonstrated that no alter-
ations in the renal histology were observed in any of
the bile duct-ligated rats compared to the sham-operated
animals [3,27]. The kidneys of the BDL/albumin-treated
rats showed some recovery with inflammatory cell infil-
tration. Some regenerated tubules appeared in the renal
medulla.
5.  Conclusion
Albumin decreased tubulointerstitial lesions in the
kidney induced by bile duct ligation in rats. These effects
of albumin may be related to improved liver function
or to their impact on oxidative stress, which is the most
common cause of remote organ damage in liver cirrhosis.
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